Jaana Korhonen

Title: Jaana Korhonen: Innovator in Tumor Imaging and Therapy

Introduction

Jaana Korhonen is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of cancer research, particularly in tumor imaging and anti-tumor therapy. With a total of five patents to her name, her work has the potential to impact the medical community profoundly.

Latest Patents

Among her latest patents is the invention titled "FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy." This invention provides purified Flt4 receptor tyrosine kinase polypeptides and fragments thereof, along with polynucleotides encoding such polypeptides, antibodies that specifically bind to these polypeptides, and their various uses. Another notable patent is "Antibodies to Flt4, a receptor tyrosine kinase and uses thereof," which similarly offers purified Flt4 receptor tyrosine kinase polypeptides and their applications.

Career Highlights

Jaana has worked with notable organizations such as Helsinki University Licensing Ltd. and the Ludwig Institute for Cancer Research Limited. Her experience in these institutions has allowed her to develop and refine her innovative ideas in cancer treatment.

Collaborations

Jaana has collaborated with esteemed colleagues, including Kari Alitalo and Olga Aprelikova. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Jaana Korhonen's work in the field of tumor imaging and therapy exemplifies the impact of innovation in medical research. Her patents and collaborations highlight her commitment to advancing cancer treatment and improving patient outcomes.